Vraylar - Drug Details
๐Ÿ“Š Estimates Vraylar Dialyzability By Different_Modalities

Vraylar

Complete Drug Information

Drug Name
Vraylar
Trade Names
Vraylar, Reagila, Symvenu
Pregnancy Category
AU: D
Bioavailability
High
Routes of Administration
Oral
Protein Binding
91โ€“97%%
Metabolism
Liver via CYP3A4 and to a lesser extent CYP2D6
Elimination
2โ€“4 days for parent drug, and 1โ€“3 weeks for active metabolites
Excretion
Urine (21%), bile
Formula
C21H32Cl2N4O
Molar Mass
427.41
Drug Class
Atypical antipsychotic
Volume of Distribution
C21H32Cl2N4O

๐Ÿคฐ Pregnancy Category Information

Category: AU: D

Drugs which have caused, are suspected to have caused, or may be expected to cause an increased incidence of human fetal malformations or irreversible damage. These drugs may also have adverse pharmacological effects.